First, directly or indirectly targeting SBF2-AS1 to suppress its expression through ASOs, CRISPR/CAS9 or biological molecules may be a viable remedy for cancers as mentioned above, in the future, especially for some current refractory tumors. Here, SBF2 is linked to cancer.